Mikaela Velazquez-Sosa

Mikaela Velazquez-Sosa

Auto-generated profile, based on publicly available information

Mikaela Velazquez-Sosa

Lombardi Comprehensive Cancer Center, Georgetown University, 2115 Wisconsin Ave NW, Suite 300, Washington, DC, 20007, United States, +1 202-687-5086

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 October 2025 in JMIR Formative Research
Verified
Journal Article
Open access
CCClaire Conley
Claire Conley
EAElizabeth L Addington
Elizabeth L Addington
MVMikaela Velazquez-Sosa
Mikaela Velazquez-Sosa
BMBrenna Mossman
Brenna Mossman
LGLesley Glenn
Lesley Glenn
JMJudith T Moskowitz
Judith T Moskowitz
Background: Depression and anxiety are prevalent among patients with metastatic breast cancer (MBC), but there are few evidence-based psychological interventions specifically designed for this population. Objective: This study aimed to assess the feasibility, acceptability, and clinical impact of a multicomponent positive psychological intervention, enhanced with an ecological momentary intervention for symptom management, for patients with MBC. Methods: We recruited patients with MBC from a National Cancer Institute–designated comprehensive cancer center. Participants completed 5 weekly virtual individual sessions with a study counselor focused on positive emotion regulation skills. Participants also reported physical and psychological symptoms daily between sessions via SMS text messaging. Clinically elevated symptoms triggered a personalized coaching SMS text message tailored to the symptoms reported and the skills learned that week. Primary outcomes were intervention feasibility and acceptability. We also examined pre- to postintervention changes in depression, anxiety, positive affect, and positive emotion regulation skill use. Finally, a subset of participants completed qualitative exit interviews focusing on their experience in the study; interview data were analyzed using rapid qualitative analysis. Results: We approached 20 patients with MBC, established contact with 15 (75%), received consent from 10 (67%), and retained 9 (90%) patients through the end of the study. Participants were 55 (SD 14.4, range 35-75) years old on average and identified as non-Hispanic White (5/10, 50%), non-Hispanic Black (4/10, 40%), or Latina (1/10, 10%). Participants attended 92% (46/50) of intervention sessions (mean 50, SD 9, range 36‐71 min). On average, they completed 85% (SD 18%, range 46%-100%) of daily symptom assessments and received 23 (SD 5, range 13‐31) coaching messages. Participants reported high perceived intervention feasibility (mean 4.81/5, SD 0.44), acceptability (mean 4.78/5, SD 0.33), and appropriateness for patients with MBC (mean 4.83/5, SD 0.35), above our a priori cutoff of ≥4. All 9 participants (n=9, 100%) recommended the intervention for other patients with MBC. We observed pre- to postintervention decreases in depression (d=−0.32) and anxiety (d=−0.27) and increases in positive affect (d=0.30) and positive emotion regulation skill use (d=0.99). Rapid qualitative analysis results demonstrate participants’ positive experiences with the intervention, as well as suggestions for improvement. Conclusions: This pilot study supports the feasibility of enrolling and retaining racially and ethnically diverse patients with MBC to this trial, the acceptability of the positive psychological intervention enhanced with ecological momentary intervention, and preliminary intervention impacts on depression, anxiety, positive affect, and positive emotion regulation skill use. A large-scale randomized controlled trial is needed to assess intervention efficacy for outcomes of interest.

3 March 2026 in JMIR Cancer
Verified
Journal Article
Open access
ETEmily P Taylor
Emily P Taylor
BMBrenna Mossman
Brenna Mossman
MVMikaela A Velazquez-Sosa
Mikaela A Velazquez-Sosa
ZRZaynab Rashid
Zaynab Rashid
NKNatalie Kloster
Natalie Kloster
CCClaire Conley
Claire Conley
Background: Patients with metastatic breast cancer (MBC) experience significant quality-of-life decrements, but there are few supportive care interventions specifically designed for this group that significantly improve quality of life. Ecological momentary assessment (EMA) and related ecological momentary interventions (EMIs) may be particularly beneficial for patients with MBC. However, no studies have previously examined the use of EMIs in the context of metastatic cancer. Objective: The purpose of this study was to qualitatively assess experiences with EMA and preferences for intervention content and mode among patients living with MBC, with an emphasis on EMIs. Methods: Women with MBC (n=29) were recruited from a longitudinal, observational study of quality of life using an EMA design. In-depth qualitative interviews assessed participants’ perspectives on the EMA design, including its feasibility, acceptability, and relevance to participants’ MBC experiences. Guided by participants’ EMA data, the interviews also examined the impact of self-monitoring and possible interventions when patients reported high symptom burden and/or low quality of life. Interviews were audio-recorded, transcribed verbatim, and analyzed using open coding, axial coding, and selective coding. The codebook was developed by reviewing a randomly selected subset of transcripts (n=5) and creating inductive, data-driven codes using the raw data, which were deductively organized into overarching themes. Results: Participants were mainly White (17/29, 59%), heterosexual (23/29, 79%), currently working (17/29, 59%), and held at least a bachelor’s degree (17/29, 59%). Participants had been living with MBC for a median of 2.5 years (range 0.2‐16.6 years). Most were diagnosed with hormone receptor-positive (23/29, 79%) and HER2-negative (21/29, 72%) breast cancer. Qualitative analysis identified 5 major themes. The participants reflected on their reasons for enrolling in the study, including interest in study activities and giving back to the MBC community (theme 1: participant engagement). Most participants found the EMA format easy to complete, and they provided recommendations for improving the design of future studies, including altering the timing and frequency of questionnaires (theme 2: feedback on study design). While less common, some participants discussed how engaging with the EMA protocol altered their experiences or behaviors (theme 3: impact of self-monitoring). Participants also discussed their reactions to seeing their EMA data, including their mixed thoughts on real-time data sharing (theme 4: responses to data). Finally, participants suggested programs and resources to improve their overall quality of life, reflecting on their interest in real-time interventions and peer-to-peer support (theme 5: recommendations for future interventions). Conclusions: Patients with MBC are willing to use EMA methodologies for data collection on quality of life and are open to EMIs with varying content and formats. Given variations in daily functioning between and within patients, a just-in-time adaptive intervention framework may be well suited for this population.